CTMX

Conviction 32HealthcareScan · Thu, Jun 25, 2026

CTMX$3.28-1.36%

ResistanceSupportVol 14

Vol MA14 4.92M

Mar 26Apr 14May 1May 19Jun 8Jun 25

CytomX Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.cytomx.com ↗

Price3.28

Change-1.36%

Gap-0.90%

Rel volume2.21×

Avg volume4.61M

Avg $ vol14.42M

SMA 203.14

SMA 503.72

SMA 2004.08

Price vs 50-12.06%

Price vs 200-19.68%

MA stackbearish

50/200 cross—

Supertrenddown · 3.48

RSI (14)48

MACD hist0.07

MACD crossbull · 5d

Stoch %K / %D79 / 78

ADX (14)28

+DI / −DI21 / 22

RSI divergence—

MACD divergence—

ATR %+5.68%

ADR %5.54%

52w high6.75

52w low1.76

From 52w high-51.48%

Above 52w low+86.08%

New 52w highNo

SqueezeOff

Bollinger width28.55%

%B0.65

Donchian pos43.19%

Donchian high3.88

Donchian low2.82

AVWAP (52w high)4.86

vs AVWAP high-32.65%

AVWAP (52w low)4.34

vs AVWAP low-24.58%

OBV trendDown

Chaikin MF (20)-0.22

Today vs 20d2.21×

Avg vol (14d)4.92M

Avg vol (20d)4.61M

Avg $ vol (20d)14.42M

Market cap712.98M

RS 3m (vs SPY)-33.96%

RS 6m (vs SPY)-24.74%

RS line new highNo

Trend template3/8

Technical rank21.1

1 week+10.64%

1 month-11.25%

3 months-22.39%

6 months-20.51%

1 year+53.04%

YTD-22.94%

P/E-41.05

P/B2.23

P/S9.36

P/FCF-9.41

EPS-1.16

Div yield—

ROE-5.43%

ROA-4.83%

Debt/Eq0.01

Current10.38

EV/EBITDA-33.55

Gross margin—

Net margin-22.79%

Rev growth-44.82%

EPS growth-154.50%

Price target11.83

Target upside261.22%

Analyst ratingBuy

Institutional93.11%

Ent. value687.14M

Revenue10.26M

Net income-18.25M

Gross profit—

Free cash flow-75.81M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out217.7M

Employees69

ListedThu, Oct 8, 2015

Free float199.76M

Float %91.8%

Short interest28.72M

Days to cover9.3d

Short volume57.6%

Squeeze score80 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.11 · 3 est

Last EPS vs est−$0.10 vs −$0.14

Last surprise+28.6% beat

Setup gradeD

Conviction32 / 100

Pattern quality—

Tech rank21.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.31

Support2.84

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CTMX

All disclosures →

No recent disclosed trades by Congress in CTMX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CTMX · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Su Zhen Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Jones Elaine V Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Gilbert Halley E Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Ashworth Alan Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Meyers James R Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Mohindru Mani Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22
Young Matthew P. Director · Stock Option (Right to Buy) · 2026-06-17	Grant	59K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in CTMX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.